Stryker Corporation ($SYK) Stock Forecast: Down 5.3% Today

What is Stryker Corporation?

Stryker (SYK) is a medical technology company known for its orthopedic implants, surgical equipment, and neurotechnology products. The company boasts a market capitalization of $153.44 billion.

Why is Stryker Corporation going down?

SYK stock is down 5.3% on Aug 1, 2025 13:47

• Despite surpassing earnings and revenue projections in Q2, Stryker (SYK) witnessed a downturn in its stock performance.
• Concerns regarding increased costs and tariffs potentially impacted margins, influencing market sentiment negatively.
• Comparisons made by investors between Stryker (SYK) and peers like SNN might have contributed to the bearish trend.
• Although Stryker (SYK) has demonstrated strong long-term growth over the last two decades, short-term apprehensions may have outweighed this performance, leading to the recent market decline.

SYK Price Chart

SYK Technical Analysis

SYK News

Stryker ( SYK ) Q2 Earnings and Revenues Beat Estimates

Stryker (SYK) delivered earnings and revenue surprises of +2.29% and +1.09%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

https://www.zacks.com/stock/news/2645663/stryker-syk-q2-earnings-and-revenues-beat-estimates

If You Invested $100 In This Stock 20 Years Ago, You Would Have This Much Today - Stryker ( NYSE:SYK )

Stryker SYK has outperformed the market over the past 20 years by 2.17% on an annualized basis producing an average annual return of 10.71%. Currently, Stryker has a market capitalization of $153.44 billion.

https://www.benzinga.com/insights/news/25/07/46763381/if-you-invested-100-in-this-stock-20-years-ago-you-would-have-this-much-today

Will SYK's Q2 Earnings Reflect Strong Growth Despite Tariff Overhang?

Stryker's second-quarter 2025 results are expected to reflect strong segmental performance. However, rising costs and tariffs are likely to have continued to hurt margins.

https://www.zacks.com/stock/news/2633272/will-syks-q2-earnings-reflect-strong-growth-despite-tariff-overhang

SNN or SYK: Which Is the Better Value Stock Right Now?

SNN vs. SYK: Which Stock Is the Better Value Option?

https://www.zacks.com/stock/news/2629394/snn-or-syk-which-is-the-better-value-stock-right-now

A Look Into Stryker Inc's Price Over Earnings - Stryker ( NYSE:SYK )

In the current session, the stock is trading at $397.65, after a 0.25% increase. Over the past month, Stryker Inc. SYK stock increased by 2.28%, and in the past year, by 20.52%.

https://www.benzinga.com/insights/news/25/07/46640344/a-look-into-stryker-incs-price-over-earnings

Trending Today

Monero ($XMR) Crypto Forecast: Down 5.2% Today

Bitcoin Cash ($BCH) Crypto Forecast: Down 5.4% Today

Arista Networks Inc. ($ANET) Stock Forecast: Down 5.2% Today

Ethereum ($ETH) Crypto Forecast: Down 5.6% Today

Amazon.com Inc. ($AMZN) Stock Forecast: Down 8.2% Today

Pacific Gas & Electric Co. ($PCG) Stock Forecast: Up 2.2% Today

LyondellBasell Industries NV Class A (Netherlands) ($LYB) Stock Forecast: Down 6.8% Today

Peloton Interactive Inc ($PTON) Stock Forecast: Down 7.4% Today

Avantor, Inc. ($AVTR) Stock Forecast: Down 17.0% Today

Ethena ($ENA) Crypto Forecast: Down 5.2% Today

Stryker Corporation Price History

01.07.2025 - SYK Stock was down 5.3%

• Despite surpassing earnings and revenue projections in Q2, Stryker (SYK) witnessed a downturn in its stock performance.
• Concerns regarding increased costs and tariffs potentially impacted margins, influencing market sentiment negatively.
• Comparisons made by investors between Stryker (SYK) and peers like SNN might have contributed to the bearish trend.
• Although Stryker (SYK) has demonstrated strong long-term growth over the last two decades, short-term apprehensions may have outweighed this performance, leading to the recent market decline.

07.02.2025 - SYK Stock was down 5.7%

• Despite recent product launches like Steri-Shield 8 and Sync Badge, SYK stock observed a bearish trend today.
• The market response could be attributed to broader market conditions or profit-taking following a period of considerable outperformance.
• Investor sentiments may be influenced by potential challenges in the healthcare field, such as regulatory modifications or competitive pressures impacting SYK's future growth.
• It is noteworthy that short-term stock fluctuations may not consistently mirror the enduring value and potential of a company like Stryker, known for providing substantial returns to investors across the years.

15.06.2024 - SYK Stock was down 0.9%

• Despite Stryker's strong performance over the years and a diversified product portfolio, the stock experienced a bearish movement recently.
• The preliminary Q2 results of Masimo (MASI) showing strength in the healthcare business might have shifted investor focus away from Stryker.
• The comparison between EYE and SYK as value stocks could have led to some investors favoring the former over the latter, impacting SYK's stock price negatively.
• While Stryker's flagship Mako Total Knee Platform has been driving optimism, market dynamics or external factors may have influenced the recent bearish trend.

02.04.2025 - SYK Stock was up 0.4%

• SYK exceeded Q1 earnings and revenue estimates, showcasing strong financial performance and exceeding market expectations.
• The company's consistent outperformance over the past decade has attracted investor interest, leading to a bullish movement in the stock.
• Expectations of strong segmental performance in Q1 further fueled investor confidence in SYK's growth prospects.
• The comparison with other companies like AHCO and ISRG highlights SYK's position as a valuable stock in the medical technology industry, contributing to its bullish market movement.

10.03.2025 - SYK Stock was down 5.5%

• Possible reasons for the decline in SYK stock today:
• Investors favoring PBH, a competitor in the same sector, over SYK due to perceived differences in value.
• Worries regarding SYK's growth outlook or financial results relative to its industry peers.
• Market instability and general economic conditions affecting overall investor trust in the healthcare products industry.

10.10.2023 - SYK Stock was up 0.0%

• Stryker's stock had a strong bullish movement today, despite a decline in Q3 profits.
• The upgrade from StockNews.com, changing the rating from hold to buy, likely contributed to the positive market movement.
• The news of Stryker's sales surpassing expectations also played a role in boosting investor confidence.
• The increase in holdings by Citizens Financial Group Inc. RI and Sequoia Financial Advisors LLC may have further fueled the bullish sentiment.

23.06.2025 - SYK Stock was up 1.2%

• SYK's strong bullish movement today could be attributed to its consistent outperformance in the market over the past decade, with an impressive average annual return of 14.76%.
• The comparison between Intuitive Surgical and Stryker in the robotic surgery sector might have sparked investor interest in SYK, highlighting its potential as a strong investment opportunity.
• The news of Representative Thomas Kean selling a portion of Stryker stock may have initially caused some uncertainty, but the market quickly rebounded, showcasing confidence in the company's long-term growth prospects.
• Overall, SYK's bullish trend today reflects investor confidence in the company's leadership in orthopedic surgeries and its ability to deliver consistent returns, despite minor fluctuations in stock transactions.

01.01.2024 - SYK Stock was up 6.1%

• Canaccord upgraded Stryker to buy, citing its growth potential, which likely contributed to the bullish movement.
• Stryker's quarterly earnings results exceeded estimates, reflecting strong performance across its segments and geographies.
• The CEO's discussion of offensive M&A goals in 2024 and the company's organic growth may have also fueled investor confidence.
• The surprising 21% stock rally further indicates positive market sentiment towards Stryker Corporation.

26.08.2023 - SYK Stock was down 5.0%

• The article comparing HAE and SYK might have caused some investors to reassess the value of SYK, potentially leading to selling pressure.
• The positive news about Neogen's improving market leadership might have highlighted a potential competitor in the industry, impacting investor sentiment towards SYK.
• The articles about the growth of the gastroscopes and implantable medical devices markets could have raised concerns about the market share and future growth prospects of SYK.
• The news about the flow diversion aneurysm treatment market growth might have diverted investor attention away from SYK, leading to a decline in its stock price.

11.09.2023 - SYK Stock was down 2.8%

• Short interest in Stryker has increased by 14.29%, indicating a bearish sentiment among traders.
• The high short percent of float suggests that there is a significant number of investors betting against the stock.
• The increased short interest may be due to concerns or negative expectations about the company's performance or future prospects.
• Traders would take 2.68 days to cover their short positions, indicating that there is a substantial amount of selling pressure on the stock.

15.06.2024 - SYK Stock was down 1.0%

• The bearish movement in SYK's stock today could be attributed to a recent comparison of Boston Scientific and its competitors in the Health Care Equipment & Supplies industry.
• Investors might have reacted to a detailed examination of key financial metrics and growth prospects, potentially leading to a shift in sentiment towards Stryker Corporation.
• The competitive analysis shedding light on Boston Scientific's market standing and growth prospects may have raised concerns among investors about Stryker's position in the industry, prompting the bearish movement in the stock.
• This comparison could have sparked a reevaluation of Stryker's market competitiveness and growth potential, leading to a decline in the stock price as investors adjusted their positions based on the industry comparison.

17.06.2024 - SYK Stock was up 3.5%

• Stryker (SYK) recently finalized the acquisition of Artelon, a strategic move to strengthen its position in the soft tissue fixation market. This acquisition has likely bolstered investor confidence in the company's growth trajectory.
• A comparative analysis of EYE and SYK in terms of value might have also attracted increased attention to Stryker's stock, with investors scouting for robust investment prospects in the healthcare sector.
• In essence, Stryker's positive market performance today can be linked to the encouraging updates regarding the acquisition and its perceived value proposition relative to other market stocks.